Every hour, over 1,000 people die from strokes and heart attacks caused by high blood pressure. That’s not a stat from the 1990s—it’s from the WHO’s 2025 Global Hypertension Report. The world has 1.4 billion hypertensive adults, yet only 320 million—about 23%—have their condition under control.
This gap is exactly why blood pressure monitoring wearables are having a moment. But here’s the problem: not all “BP watches” work the same way. The difference between a clinically validated device and a gadget that just shows numbers can mean the difference between catching a dangerous spike and missing it entirely.
If you’re an enterprise buyer, healthcare provider, or brand looking to source or customize blood pressure wearables, you need to understand the technology—not the marketing fluff. This guide breaks it down.
Two Paths, One Goal: How Wearable BP Monitors Actually Work
Blood pressure measurement in wearables falls into two distinct categories. The tech you choose affects accuracy, cost, regulatory pathway, and market positioning.
Oscillometric Cuff-Based: The Clinical Standard
These devices integrate a miniature inflatable cuff (or air bag) into the watch strap. When you trigger a measurement, the pump inflates, occludes the radial artery, then gradually deflates while sensors detect oscillations in the arterial wall.
This is the same oscillometric principle used in hospital-grade upper-arm monitors. It’s been validated for decades and is the only method currently recognized by regulatory bodies like the FDA and EU MDR for direct BP measurement.
Key specs for clinical-grade cuff-based devices:
- Accuracy: ±5 mmHg systolic / ±4 mmHg diastolic (ISO 81060-2:2018 standard)
- Requires stillness during measurement (30-60 seconds)
- Wrist must be at heart level
- Typical inflation/deflation cycle: 40-60 seconds
Real-world example: The Omron HeartGuide (FDA 510(k) cleared in 2019) and Huawei Watch D2 (FDA cleared + EU MDR Class IIa) both use oscillometric cuffs. Independent clinical trials show mean errors of ≤±3 mmHg systolic under controlled conditions.
PPG-Based Cuffless Estimation: Convenient but Limited
Most “BP tracking” smartwatches on the market use photoplethysmography (PPG) sensors—tiny LEDs that shine light into the skin and measure reflected light absorption changes caused by blood volume pulses.
PPG is excellent for heart rate and SpO2. But blood pressure? That’s where it gets tricky.
PPG-based BP estimation works by applying algorithms that try to infer BP from pulse wave transit time (PTT), pulse waveform characteristics, or correlation models trained on reference cuff data. The problem:
- Single-point calibration drifts over time
- Motion, temperature, skin tone, and wrist circumference affect readings
- Common errors: ±15-25 mmHg during movement or posture changes
- Not validated for clinical diagnosis under most regulatory frameworks
Consumer Reports explicitly states: “None of the PPG-based smartwatches we tested met the minimum accuracy requirements for clinical use.”
However, there’s nuance. In January 2026, the FDA issued new guidance allowing cuffless optical BP features in the “wellness” category—as long as companies avoid medical-grade claims. This opened doors for PPG-based hypertension screening features without full 510(k) clearance.
The Regulatory Maze: What FDA Clearance Actually Means in 2025-2026
Blood pressure wearables exist in a rapidly evolving regulatory landscape. Understanding this isn’t optional—it’s critical for any B2B buyer or brand sourcing these products.
FDA 510(k) vs. PMA: What’s the Difference?
Two pathways to market, very different requirements:
510(k) Clearance: The manufacturer demonstrates “substantial equivalence” to an already legally marketed predicate device. This is the standard pathway for BP monitors. Product code: DXN (Noninvasive Blood Pressure Measurement System).
PMA (Premarket Approval): Required for novel, high-risk devices. Requires extensive clinical trials proving safety and effectiveness. Reserved for truly innovative devices with no suitable predicate.
Most cuff-based BP smartwatches pursue 510(k). Cuffless PPG estimation devices typically cannot get BP-specific clearance without clinical validation—hence the “wellness feature” workaround.
Apple’s Hypertension Notification: A New Category
In September 2025, Apple received FDA clearance for its Hypertension Notification Feature on Apple Watch Series 9 and later. This was significant because:
- It’s the first FDA-cleared hypertension screening feature in a major smartwatch platform
- It doesn’t display BP numbers—it passively analyzes 30 days of PPG data and alerts users to patterns suggestive of hypertension
- Clinical trial: 100,000+ participants, 1,863 in controlled study
- Sensitivity: ~41%, Specificity: ~92%
Apple’s algorithm detects patterns, not absolute values. If you get an alert, the recommendation is to follow up with a clinical BP measurement within 7 days. This is pattern-based public health screening, not diagnostic measurement.
The WHOOP Incident: When “Wellness” Goes Too Far
In 2025, WHOOP received an FDA warning letter for marketing BP estimation features without authorization. The FDA stated that devices making BP claims “do not fall within the FDA’s policy for general wellness products because they are not intended solely for a general wellness use and are not low risk.”
WHOOP appealed but continued similar marketing. Then, in early 2026, the FDA pivoted with new guidance: optical BP estimation can stay in the wellness category as long as companies make no “medical-grade” data claims.
Takeaway: The regulatory line is evolving. “Wellness” is okay; “medical-grade accuracy” is not—unless you have the clearance to back it up.
Clinical-Grade BP Wearables: Technology Comparison
Here’s how validated cuff-based BP monitoring systems compare on key specs:
| Parameter | S10 Pro (Xdun) | TK67 (Xdun) | BP100E (Xdun) | Omron HeartGuide | Huawei Watch D2 |
|---|---|---|---|---|---|
| Method | Oscillometric (Air Pump) | Oscillometric (Air Pump) | Oscillometric (Air Pump) | Oscillometric (Air Pump) | Oscillometric (Air Pump) |
| Display | 1.78″ OLED | 1.95″ AMOLED | 1.9″ Color | 1.28″ OLED | 1.92″ LTPO AMOLED |
| BP Accuracy | ABPM Standard | Clinical Grade | Clinical Grade | ±5/4 mmHg (ISO) | ±3/2 mmHg (ISO) |
| 4G LTE | Yes Standalone | – | Yes | – | – |
| SOS/Fall Detection | Yes | – | Yes | – | – |
| Battery | 700mAh (>3 days) | 530mAh | 400mAh | Not disclosed | Not disclosed |
| IP Rating | IP65 | IP67 | IP67 | IP68 | IP68 |
| Additional | ECG, SpO2, Temp, Cloud | ECG, PPG, Blood Glucose | SOS, Fall Detection | Steps, Sleep | ECG, SpO2, Temp |
| OEM/ODM Available | Yes | Yes | Yes | Enterprise only | Enterprise only |
Note: All oscillometric cuff-based devices listed meet clinical measurement standards when used according to instructions. PPG-based estimation devices (Apple Watch hypertension notification, WHOOP, most budget watches) are not included as they measure differently.
OEM/ODM Selection Guide: Choosing the Right BP Monitor Partner
Whether you’re launching a branded BP smartwatch, sourcing for a hospital program, or building a remote patient monitoring platform, the OEM/ODM partner you choose determines:
- Time to market
- Regulatory pathway feasibility
- Per-unit economics
- Customization depth
1. Define Your Target Market First
US/Europe medical market: You need clinical validation (ISO 81060-2:2018) and regulatory clearance support (FDA 510(k), CE MDR). Oscillometric cuff technology is non-negotiable. Budget for 6-12 months of compliance work.
Asia-Pacific / emerging markets: Local regulations vary. NMPA (China), TGA (Australia), and other certifications may be required. PPG-based products may be acceptable for consumer wellness positioning.
Healthcare institution procurement: Hospitals and clinics typically require clinical accuracy documentation, EMR integration capability, and reliable supply chain for device support and replacement.
2. Technology Decision: Cuff or No Cuff?
Ask yourself:
- Will users make medical decisions based on readings? → Cuff-based is required
- Is this for screening/awareness only? → PPG may suffice with clear disclaimers
- Do you need 24-hour ambulatory monitoring? → Cuff-based ABPM is standard
- Is user experience paramount (no inflation discomfort)? → PPG (with accuracy caveats)
3. Certification Support: Critical Differentiator
A good OEM partner should:
- Support FDA 510(k) submissions with documentation packages
- Provide clinical validation study data
- Assist with CE MDR technical files
- Offer ISO 13485 quality management system documentation
Red flag: An OEM that promises “FDA cleared” products without discussing validation protocols, or that sells the same device to multiple clients claiming individual clearances—because each 510(k) is device-specific.
4. Customization Depth
What can be customized?
- Hardware: Display size, battery capacity, sensor modules (add/remove ECG, SpO2, temperature)
- Industrial design: Case materials, color options, button layout
- Algorithms: Custom BP calibration curves, health scoring models
- Software: Branded app, cloud platform, EMR integration APIs
- Certifications: Different markets may require separate certification processes
5. Supply Chain and Volume Considerations
For medical devices:
- Component traceability is mandatory (ISO 13485)
- Consistency matters more than lowest price
- Long-term support commitments are essential
- MOQ (Minimum Order Quantities) typically higher than consumer electronics
Geyan Technology Innovation: Your BP Monitoring OEM/ODM Partner
Geyan Technology Innovation Technology specializes in clinical-grade blood pressure wearables with full OEM/ODM capabilities. Our product line includes:
S10 Pro Wrist-Worn ABPM: Designed for continuous 24/7 blood pressure monitoring with 4G LTE standalone connectivity. Features oscillometric air pump technology, one-touch SOS, cloud-based threshold alerts, and 700mAh battery for >3 days continuous operation. Ideal for remote patient monitoring programs.
TK67 Air Pump BP Watch: Consumer-facing form factor with clinical-grade accuracy. 1.95″ AMOLED display, ECG+PPG dual sensors, blood glucose and lipid trend monitoring. IP67 waterproof. Perfect for branded health platforms targeting the hypertension management market.
BP100E 4G BP Watch: Built for senior care and assisted living applications. 4G LTE with SOS emergency and fall detection. Combines clinical BP measurement with safety features that healthcare institutions require.
All devices support:
- Custom branding (logo, packaging, startup screen)
- Custom app and cloud platform development
- Multi-market certification support (FDA, CE, regional)
- Flexible MOQ for market testing and enterprise deployment
Frequently Asked Questions
Q1: What’s the difference between FDA “cleared” and FDA “approved”?
FDA “cleared” typically refers to devices that received 510(k) clearance by demonstrating substantial equivalence to a predicate device. FDA “approved” requires PMA (Premarket Approval), a more rigorous process for high-risk novel devices. Most blood pressure monitors on the market have 510(k) clearance, not PMA approval.
Q2: Can PPG-based smartwatches accurately measure blood pressure?
Current PPG technology cannot directly measure blood pressure. PPG-based “BP tracking” estimates BP using algorithms trained on limited reference data. Consumer Reports testing shows errors of ±15-25 mmHg common, especially during movement. This is why regulatory bodies have not cleared PPG devices for clinical BP measurement—the technology exists, but accuracy hasn’t been validated to clinical standards.
Q3: How long does FDA 510(k) clearance take for a BP wearable?
Typical timeline: 6-12 months from submission to clearance, assuming no review delays or additional information requests. This includes preparation of the submission, FDA review (which averages 4-6 months), and any back-and-forth. A complete technical file with clinical validation data significantly speeds up the process.
Q4: What’s ABPM and why does it matter?
ABPM stands for Ambulatory Blood Pressure Monitoring—the gold standard for diagnosing hypertension. It involves wearing a device that measures BP at regular intervals (typically every 15-30 minutes) over 24 hours. This captures the full picture: daytime vs. nighttime readings, white-coat hypertension, and masked hypertension. Devices like the Xdun S10 Pro are specifically designed for ABPM applications.
Q5: What certifications should a medical-grade BP wearable have?
For global market access: FDA 510(k) (US), CE MDR (EU), ISO 13485 (quality management), IEC 60601-1 (electrical safety), IEC 60601-1-2 (EMC). Regional requirements vary: NMPA (China), TGA (Australia), Health Canada, etc. Ask your OEM partner for a complete regulatory roadmap based on your target markets.
Next Steps: Get Started with Your BP Wearable Project
Whether you’re launching a new product line, sourcing for a healthcare program, or exploring customization options for existing platforms, Geyan Technology Innovation’s engineering team can help you navigate the technical and regulatory landscape.
What we offer:
- Technical consultation on BP monitoring technology selection
- Regulatory pathway planning (FDA, CE, regional)
- Customization scope and feasibility assessment
- Prototype and proof-of-concept programs
- Volume pricing and supply chain planning
Contact our B2B team at jine@xdunmedical.com or call +86-139-2558-7509 to discuss your project requirements.